Aksìa Group acquired 100% stake of Lameplast COC Group

Fineurop Soditic acted as financial adviser to the private equity firm Aksìa Group in the acquisition of 100% stake of Lameplast COC Group.

The Group is the European leading provider of single-dose packaging and contract manufacturing, mainly used in the ophthalmic and healthcare segments. Lameplast Group operates in Italy via Lameplast S.p.A. and COC Farmaceutici S.r.l. and in North America via a commercial branch in the United States. Founded in 1956 in Carpi (Modena), Lameplast produces single and multi-dose strips and other specialty plastic packaging with injection technology in a sterile environment. COC has plants in Carpi and near Bologna and operates as contract manufacturer for research, production and filling of pharmaceuticals and medical devices, both in single-dose and commercialized plastic containers. In 2014, Lameplast COC Group reported sales of €43 million with an EBITDA margin of around 17%.

 

All transactions